PHARMACOLOGICAL TREATMENT OF OCULAR DEVELOPMENT

摘要

A composition for the inhibition of abnormal postnatal axial growth of the eye, in a maturing animal, is described. The composition includes an effective amount of a neurochemical, its agonist, or its antagonist which is found to be changed in concentration under conditions which ordinarily lead to abnormal ocular growth, during postnatal maturation, and which therefore contribute toward sight defects such as myopia.